Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sudhashree Rajagopal"'
Autor:
Tara Baetz, Teresa M. Petrella, G. Knight, Xinni Song, Glenn G. Fletcher, Sudhashree Rajagopal, Elaine McWhirter
Publikováno v:
Current Oncology
Volume 27
Issue 1
Pages 5933-52
Volume 27
Issue 1
Pages 5933-52
Previous versions of the guideline from the Program in Evidence-Based Care (pebc) at Ontario Health (Cancer Care Ontario) recommended that the use of high-dose interferon alfa 2b therapy be discussed and offered to patients with resected cutaneous me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::212d410b4bf7d324d0be3e59c22e09f5
https://doi.org/10.3747/co.27.5933
https://doi.org/10.3747/co.27.5933
Autor:
Sudhashree Rajagopal, Catalin Mihalcioiu, R. Koneru, D.S. Ernst, Michael Smylie, L. Liu, Femida Gwadry-Sridhar, Tina Cheng, Xinni Song, Marcus O. Butler, Tara Baetz, H. McConkey, Teresa M. Petrella
Publikováno v:
Annals of Oncology. 30:v553
Background The widespread introduction of ICIs in patients (pts) with metastatic disease has significantly improved outcomes. However, ICIs in the elderly requires further evaluation to determine whether outcomes differ from that observed in younger
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d88c1ed740f5373edc98215a6c0c9b63
https://doi.org/10.1093/annonc/mdz255.042
https://doi.org/10.1093/annonc/mdz255.042
Autor:
Jean-François Pouliot, Teresa M. Petrella, Richard Tozer, Andre Galarneau, Bryn Pressnail, Michael Smylie, G. Knight, Caroline M. Hamm, Tina Cheng, Jose Chang, Nancy Gregorio, Sudhashree Rajagopal
Publikováno v:
Journal of Clinical Oncology. 32:e20038-e20038
e20038^ Background: Melanoma incidence increased dramatically in the last decades. Intron A is the only adjuvant therapy shown to significantly increase progression-free and overall survival in hig...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cef1383e9b0a9ac6e80fd53d4c8c1dab
https://doi.org/10.1200/jco.2014.32.15_suppl.e20038
https://doi.org/10.1200/jco.2014.32.15_suppl.e20038
Autor:
Jeff Myers, Arun Partridge, Elizabeth Laureen Strevel, Katherine Enright, Cindy L. Quinton, Leonard Kaizer, Sudhashree Rajagopal, Mark Rother
Publikováno v:
Journal of Clinical Oncology. 31:e17503-e17503
e17503 Background: The standard of care for stage III colon cancer remains 5FU based AC. In clinical trial settings, this begins within 56 days of surgery. Recently a meta-analysis suggested that delays to starting chemotherapy are associated with in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a18279180af4e9188aa26f2a871be60
https://doi.org/10.1200/jco.2013.31.15_suppl.e17503
https://doi.org/10.1200/jco.2013.31.15_suppl.e17503